Adero Partners LLC Acquires New Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Adero Partners LLC bought a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm bought 2,100 shares of the exchange traded fund’s stock, valued at approximately $207,000.

Several other hedge funds have also recently added to or reduced their stakes in XBI. Healthcare of Ontario Pension Plan Trust Fund grew its holdings in shares of SPDR S&P Biotech ETF by 30.3% during the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock worth $297,575,000 after buying an additional 730,000 shares in the last quarter. Northwestern Mutual Wealth Management Co. grew its holdings in shares of SPDR S&P Biotech ETF by 1.6% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,145,049 shares of the exchange traded fund’s stock worth $106,158,000 after buying an additional 18,202 shares in the last quarter. Jane Street Group LLC grew its holdings in shares of SPDR S&P Biotech ETF by 68.7% during the first quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock worth $91,197,000 after buying an additional 391,333 shares in the last quarter. Bessemer Group Inc. grew its holdings in shares of SPDR S&P Biotech ETF by 1.7% during the first quarter. Bessemer Group Inc. now owns 922,871 shares of the exchange traded fund’s stock worth $87,572,000 after buying an additional 15,794 shares in the last quarter. Finally, Mirae Asset Securities USA Inc. grew its holdings in shares of SPDR S&P Biotech ETF by 50.0% during the third quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock worth $88,920,000 after buying an additional 300,000 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA XBI opened at $91.83 on Monday. The company has a market cap of $7.00 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 12 month low of $69.32 and a 12 month high of $105.47. The company has a 50-day simple moving average of $98.95 and a 200-day simple moving average of $96.17.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.